Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 12 record(s)

Req # A-2021-001016

Briefing notes between the Financial Consumer Agency of Canada (FCAC) and the Ministry of Finance between April 1, 2018, and January 15, 2021, that refer to External Complaints Bodies or ECBs and all relevant correspondences.

Organization: Financial Consumer Agency of Canada

284 page(s)
April 2021

Req # A-2021-004917

I would like a copy of a briefing note sent to the Deputy Head of the FCAC on January 27, 2021 titled "Public Opinion Research 20-21: Consumers' Awareness of their Financial Rights and Responsibilities" Ref # 360341

Organization: Financial Consumer Agency of Canada

5 page(s)
April 2021

Req # A-2021-004918

I would like a copy of a briefing note sent to the Deputy Head of the FCAC on December 18, 2020 titled "Financial Updates to the Financial Consumer Agency of Canada Act" Ref #353715

Organization: Financial Consumer Agency of Canada

3 page(s)
April 2021

Req # A-2021-004921

I would like a copy of a briefing note sent to the Deputy Head of the FCAC on December 1, 2020 titled "Market Conduct Review under the Code of Conduct for the Credit and Debit and Card Industry" Ref #354513

Organization: Financial Consumer Agency of Canada

3 page(s)
April 2021

Req # A-2020-03991

Copies of all records, analysis, correspondence, discussions, briefings, memos and decisions, about the development of the PMPRB regulations involving individuals with a classification of AS-04 and above, PM-04 and above, EC-04 and above, and EX-all levels. Also include the Minister and Political staff; between January 2016 to February 2020.

Organization: Patented Medicine Prices Review Board Canada

478 page(s)
April 2021

Req # A-2020-03992

Copies of all analysis, correspondence, discussions, briefings and memos about the evaluation of stakeholder submissions for the PMPRB regulations (including submissions relating to the 2016 PMPRB guidelines modernization, the 2017 consultations on potential changes to the PMPRB regulations, Canada Gazette Part I, and Canada Gazette Part II) involving individuals with a classification of AS-04 and above, PM-04 and above, EC-04 and above, EX-all levels. Include the Minister and Political staff; between January 2016 to February 2020.

Organization: Patented Medicine Prices Review Board Canada

323 page(s)
April 2021

Req # A-2021-05507

Copies of all communications to/from Douglas Clark regarding the timelines of CADTH and pCPA's drug review process from June 1, 2019 to March 3, 2021.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
April 2021

Req # A-2021-05508

Copies of all communications between Douglas Clark (PMPRB executive) and officials in Health Canada's Health Products and Food Branch from January 1, 2020 to March 3, 2021.

Organization: Patented Medicine Prices Review Board Canada

23 page(s)
April 2021

Req # A-2021-05509

Copies of all communications between Douglas Clark and officials in Health Canada's Health Products and Food Branch regarding the drug Trikafta from Vertex Pharmaceuticals.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
April 2021

Req # A-2021-05511

Copies of all communications between Douglas Clark and officials in CADTH and pCPA regarding the drug Trikafta.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
April 2021
Date modified: